Marianne P. Allen

Array ( [id] => 1585950 [patent_doc_number] => 06358920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Compounds and methods for modulating nonclassical cadherin-mediated functions' [patent_app_type] => B1 [patent_app_number] => 09/187859 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 7 [patent_no_of_words] => 53890 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358920.pdf [firstpage_image] =>[orig_patent_app_number] => 09187859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386271 [patent_doc_number] => 06262231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Polypeptides useful for diagnosis of Aspergillus fumigatus and a process of preparing the same' [patent_app_type] => 1 [patent_app_number] => 9/184938 [patent_app_country] => US [patent_app_date] => 1998-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 6752 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262231.pdf [firstpage_image] =>[orig_patent_app_number] => 184938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493980 [patent_doc_number] => 06342370 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Human slit polypeptide and polynucleotides encoding same' [patent_app_type] => B1 [patent_app_number] => 09/182024 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15945 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342370.pdf [firstpage_image] =>[orig_patent_app_number] => 09182024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380477 [patent_doc_number] => 06548061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration' [patent_app_type] => B1 [patent_app_number] => 09/181719 [patent_app_country] => US [patent_app_date] => 1998-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 16812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548061.pdf [firstpage_image] =>[orig_patent_app_number] => 09181719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475599 [patent_doc_number] => 06388056 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Inhibition of transglutaminase-mediated microbial interaction with a mammalian host' [patent_app_type] => B1 [patent_app_number] => 09/178509 [patent_app_country] => US [patent_app_date] => 1998-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 16896 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388056.pdf [firstpage_image] =>[orig_patent_app_number] => 09178509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356890 [patent_doc_number] => 06255075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Bira' [patent_app_type] => 1 [patent_app_number] => 9/175172 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20949 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255075.pdf [firstpage_image] =>[orig_patent_app_number] => 175172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379575 [patent_doc_number] => 06261802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Ups (ugc)' [patent_app_type] => 1 [patent_app_number] => 9/175014 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20233 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261802.pdf [firstpage_image] =>[orig_patent_app_number] => 175014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419257 [patent_doc_number] => 06225088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'DNA encoding plasminogen-like growth factor (PLGF) and related embodiments' [patent_app_type] => 1 [patent_app_number] => 9/170573 [patent_app_country] => US [patent_app_date] => 1998-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5647 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225088.pdf [firstpage_image] =>[orig_patent_app_number] => 170573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407248 [patent_doc_number] => 06228598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies' [patent_app_type] => 1 [patent_app_number] => 9/165437 [patent_app_country] => US [patent_app_date] => 1998-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6165 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228598.pdf [firstpage_image] =>[orig_patent_app_number] => 165437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294287 [patent_doc_number] => 06235884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Heparin binding mitogen with homology to epidermal growth factor (EGF)' [patent_app_type] => 1 [patent_app_number] => 9/158710 [patent_app_country] => US [patent_app_date] => 1998-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13715 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235884.pdf [firstpage_image] =>[orig_patent_app_number] => 158710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104500 [patent_doc_number] => 06811992 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'Method for identifying MLK inhibitors for the treatment of neurological conditions' [patent_app_type] => B1 [patent_app_number] => 09/156367 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12899 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/811/06811992.pdf [firstpage_image] =>[orig_patent_app_number] => 09156367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320922 [patent_doc_number] => 06331411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'TopA' [patent_app_type] => 1 [patent_app_number] => 9/153277 [patent_app_country] => US [patent_app_date] => 1998-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24257 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331411.pdf [firstpage_image] =>[orig_patent_app_number] => 153277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357424 [patent_doc_number] => 06576741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Streptoccal inhibitor of complement-mediated lysis, protein SIC' [patent_app_type] => B1 [patent_app_number] => 09/051380 [patent_app_country] => US [patent_app_date] => 1998-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12127 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576741.pdf [firstpage_image] =>[orig_patent_app_number] => 09051380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216121 [patent_doc_number] => 06110894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function' [patent_app_type] => 1 [patent_app_number] => 9/146269 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 27847 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110894.pdf [firstpage_image] =>[orig_patent_app_number] => 146269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345927 [patent_doc_number] => 06284731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function' [patent_app_type] => 1 [patent_app_number] => 9/146268 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 27267 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284731.pdf [firstpage_image] =>[orig_patent_app_number] => 146268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549860 [patent_doc_number] => 06399332 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Bacterial superantigen vaccines' [patent_app_type] => B1 [patent_app_number] => 09/144776 [patent_app_country] => US [patent_app_date] => 1998-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22560 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399332.pdf [firstpage_image] =>[orig_patent_app_number] => 09144776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506913 [patent_doc_number] => 06440678 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Materials and methods related to the inflammatory effects of secreted amyloid precursor proteins' [patent_app_type] => B1 [patent_app_number] => 09/141951 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4621 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440678.pdf [firstpage_image] =>[orig_patent_app_number] => 09141951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1350646 [patent_doc_number] => 06576238 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Ectoparasite saliva proteins and apparatus to collect such proteins' [patent_app_type] => B1 [patent_app_number] => 08/981799 [patent_app_country] => US [patent_app_date] => 1998-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 66807 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576238.pdf [firstpage_image] =>[orig_patent_app_number] => 08981799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324356 [patent_doc_number] => 06312695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Compounds and methods for therapy of lung cancer' [patent_app_type] => 1 [patent_app_number] => 9/123912 [patent_app_country] => US [patent_app_date] => 1998-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26546 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312695.pdf [firstpage_image] =>[orig_patent_app_number] => 123912 [rel_patent_id] =>[rel_patent_doc_number] =>)